Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2022studies shown
Showing 1,126-1,150 of 2,022
TerminatedNCT05211947

A Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX Study

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 18 Years to 51 Years
Countries
Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Italy, Japan, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, Philippines, Poland, Portugal, Romania, Serbia, Slovakia, South Korea, Spain, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, United States
Sponsor
Boehringer Ingelheim
Condition
Schizophrenia
CompletedNCT00942981

Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography

This study exists to see whether the medication NNC-112 can make care clearer and more responsive. Researchers are trying to understand whether the medication NNC-112 can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 90 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Schizophrenia
RecruitingNCT04226898

Synbiotic Compound to Reduce Symptoms of Schizophrenia

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Sheppard Pratt Health System
Condition
Schizophrenia
TerminatedNCT06155695

Auditory Control Enhancement (ACE) in Schizophrenia

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 40 Years
Countries
United States
Sponsor
Brian A Coffman, PhD
Condition
Schizophrenia
RecruitingNCT04887792

Acetazolamide for Treatment Resistant Schizophrenia

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
India, United States
Sponsor
Vishwajit Nimgaonkar, MD PhD
Condition
Schizophrenia
RecruitingNCT07509125

Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders

This study exists to see whether blood tests and biological markers can make care clearer and more responsive. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 90 Years
Countries
Belgium
Sponsor
Universitaire Ziekenhuizen KU Leuven
Condition
Schizophrenia
SuspendedNCT05259306

Low-Intensity Focused Ultrasound Neuromodulation of the Mediodorsal Thalamus for Treatment-Resistant Schizophrenia

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 21 Years to 80 Years
Countries
United States
Sponsor
NYU Langone Health
Condition
Schizophrenia
CompletedNCT01022489

High Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) in Schizophrenia : a Randomized Controlled Study

This study exists to see whether brain scans or other body measurements is workable and worth testing more broadly. Researchers are trying to understand whether brain scans or other body measurements can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 16 Years to 65 Years
Countries
France
Sponsor
University Hospital, Caen
Condition
Schizophrenia
RecruitingNCT03971487

Ocrelizumab for Psychosis by Autoimmunity

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand what this type of care can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
United States
Sponsor
The Methodist Hospital Research Institute
Condition
Schizophrenia
CompletedNCT01805128

Exploration of the Social Cognition in Adolescents With a Dissociative Disorder or Autism Spectrum

This study exists to compare options and see whether questionnaires and follow-up reports offers something meaningfully different. Researchers are trying to understand whether questionnaires and follow-up reports can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 12 Years to 18 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire de Nice
Condition
Schizophrenia
Not Yet RecruitingNCT05416658

Shared Decision Making for Antipsychotic Medications

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 18 Years to 30 Years
Countries
Global
Sponsor
New York State Psychiatric Institute
Condition
Schizophrenia
CompletedNCT07497516

Mindfulness-Based Yoga in Schizophrenia

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.

SchizophreniaOtherOver 18 Years
Countries
Turkey
Sponsor
Tarsus University
Condition
Schizophrenia
CompletedNCT03485417

Substance Misuse To Psychosis for Stimulants

This study exists to understand what helps a therapy or guided support program work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a therapy or guided support program can work better when mental health difficulties overlap with substance use.

SchizophreniaOtherFrom 16 Years to 50 Years
Countries
China
Sponsor
The University of Hong Kong
Condition
Schizophrenia
CompletedNCT05345184

Cognitive Behavioral Suicide Prevention for Psychosis: Aim 2

This study exists to see whether questionnaires and follow-up reports is workable and worth testing more broadly. Researchers are trying to understand whether questionnaires and follow-up reports can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Michigan
Condition
Schizophrenia
TerminatedNCT04040829

Cognitive Remediation and Supported Education in Psychotic Disorders

This study exists to see whether acceptance and commitment therapy, a talking treatment, can make care clearer and more responsive. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 16 Years to 35 Years
Countries
Canada
Sponsor
Centre de Recherche de l'Institut Universitaire en Santé Mentale de Québec
Condition
Schizophrenia
CompletedNCT03246932

Peer-led Psycho-education for Schizophrenia

This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand whether this type of care can better prevent setbacks and support longer-term stability.

SchizophreniaOtherFrom 18 Years to 64 Years
Countries
China
Sponsor
Chinese University of Hong Kong
Condition
Schizophrenia
CompletedNCT05899348

iTEST: Introspective Accuracy as a Novel Target for Functioning in Psychotic Disorders

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can make support easier to access outside standard clinic visits.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
Schizophrenia
CompletedNCT06155786

Cognitive Effects of tDCS and tRNS in Schizophrenia

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
Iran
Sponsor
The National Brain Mapping Laboratory (NBML)
Condition
Schizophrenia
CompletedNCT05693935

A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label, Long-Term Safety Phase to Evaluate the Efficacy and Safety of TV-44749 in Adults With Schizophrenia

This study exists to understand whether the medication TV-44749 is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to the medication TV-44749 in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 64 Years
Countries
Bulgaria, China, Romania, Turkey, United States
Sponsor
Teva Branded Pharmaceutical Products R&D LLC
Condition
Schizophrenia
CompletedNCT06627413

Safety, Tolerability, and Pharmacokinetics of Lumateperone Long-Acting Injectable Formulations in Patients With Schizophrenia or Schizoaffective Disorder

This study exists to better understand the safety of this type of care and how manageable it feels in practice. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Schizophrenia
CompletedNCT07453355

EXPRESSIVE ARTS THERAPY FOR HOPE IN PEOPLE WITH SCHIZOPHRENIA

This study exists to compare options and see whether psychoeducation, a guided learning and support program, offers something meaningfully different. Researchers are trying to understand what helps psychoeducation, a guided learning and support program, stay useful, realistic, and easier to follow over time.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Turkey
Sponsor
Ondokuz Mayıs University
Condition
Schizophrenia